Biosimilar Litigation Cases in Third Circuit

Browse 1 biosimilar litigation cases decided by Third Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Mixed

Biosimilar Litigation Opinions from Third Circuit (1)

Amgen Inc v. Celltrion USA Inc

CA3 Affirms Enbrel Patent Infringement, Reverses Willfulness Finding

Third Circuit · 2025-06-05 · Mixed · Impact: 60/100

Amgen Inc v. Celltrion USA Inc, decided by Third Circuit on June 5, 2025, resulted in a mixed outcome. The Third Circuit affirmed the District Court's finding of infringement of Amgen's patents for it...

Frequently Asked Questions

Q: How many biosimilar litigation cases has Third Circuit decided?

CaseLawBrief currently tracks 1 biosimilar litigation cases from Third Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in biosimilar litigation cases at Third Circuit?

Outcome breakdown: Mixed: 1.

Q: Where can I find plain English summaries of biosimilar litigation rulings from Third Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Third Circuit Cases All Biosimilar Litigation Cases All Courts All Topics Search